
Schizophrenia is one of the most common psychiatric health disorders that affect an average of one per cent of the world’s population. The most recent methods of treatment can just partially alleviate the symptoms of this disorder but many patients aren’t helped at all.
But there is good news for these patients as research team of
The understanding of this QKI gene will lead to hopeful drug research and development for schizophrenia.
Read more at In-Pharmatechnologist or at Uppsala U News.






Comment Preview